Fact CheckerSign in

NCT07486076Enrolling by invitation

OSTEOPOROSIS EDUCATION AND ITS IMPACT ON OSTEOPOROSIS HEALTH BELIEFS AND AWARENESS IN WOMEN AT RISK OF OSTEOPOROSIS

THE EFFECT OF A HEALTH BELIEF MODEL-BASED EDUCATION PROGRAMME ON OSTEOPOROSIS AWARENESS AND HEALTH BELIEFS IN WOMAN AT RISK OF OSTEOPOROSIS: A RANDOMISED CONTROLLED TRIAL

Source: ClinicalTrials.gov · Last updated 20 Aug 2026

Brief summary (registry, in English)

Osteoporosis is a significant public health problem characterized by low bone mass and deterioration in the microarchitecture of bone tissue, leading to an increased risk of fractures. Risk factors such as advanced age, female gender, inadequate calcium and vitamin D intake, physical inactivity, smoking, and alcohol use play a critical role in its development. As in many countries, the prevalence of osteoporosis is increasing in Turkey, accelerated by an aging population and lifestyle changes. However, it is reported that the level of awareness and knowledge about osteoporosis in the community is often insufficient. This study is a randomized controlled experimental trial with a two-group pretest-posttest design, conducted between February 1 and June 1, 2026, among women aged 45 and older who have not been diagnosed with osteoporosis but carry at least one osteoporosis risk factor, attending the Physical Therapy and Rehabilitation outpatient clinic at Bartın State Hospital. From the study population, participants who meet the inclusion criteria and volunteer will be randomly assigned to intervention and control groups. The sample size is determined as 74, calculated with a 95% confidence level and a 5% margin of error. While the intervention group receives a structured education program based on the Health Belief Model, the control group will receive no education. The dependent variables of the study are osteoporosis awareness and health beliefs. These variables will be measured before and after the intervention using the Osteoporosis Awareness Scale and the Osteoporosis Health Belief Scale, which includes subdimensions of perceived susceptibility, seriousness, benefits, and barriers. The effectiveness of the education program will be evaluated through inter-group and intra-group comparisons.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
74 (estimated)
First submitted
17 Mar 2026
Start date
25 Apr 2026
Primary completion date
20 Jan 2027
Lead sponsor
Bartın Unıversity
Diseases
Osteoporosis
NCT number
NCT07486076

What you commit to

  • Study type: Interventional
  • Planned participants: 74
  • From 25 Apr 2026 to the primary completion date, 20 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having a previous diagnosis of osteoporosis

Other illness

  • Having a serious endocrine or rheumatological disease affecting bone metabolism
  • Having a history of long-term (≥ 3 months) systemic corticosteroid use
  • Having hearing, vision, or cognitive impairment that would prevent participation in the education program

Other

  • Having participated in a structured education program related to osteoporosis within the last 6 months
  • Wishing to withdraw from the study or being unable to complete the follow-up process-

Who the study is looking for

  • Inclusion Criteria: Individuals meeting the following criteria will be included in the study:
    • Being a woman aged 45 and over
    • Not having been diagnosed with osteoporosis
    • Having at least one of the risk factors for osteoporosis development as stated in the literature (being in menopause, family history of osteoporosis, low level of physical activity, insufficient calcium/vitamin D intake, low body mass index, etc.)
    • Having applied to the Physical Therapy and Rehabilitation Outpatient Clinic of Bartın State Hospital
    • Volunteering to participate in the study and signing the informed consent form
    • Having the cognitive and physical capacity to participate in the training sessions

Age in the registry: 45 years to 80 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bartın State Hospital
Coordinator of this site? Confirm its status
BartınTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.